Cargando…

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates

For decades, the spread of multidrug-resistant (MDR) Acinetobacter baumannii has been rampant in critically ill, hospitalized patients. Traditional antibiotic therapies against this pathogen have been failing, leading to rising concerns over management options for patients. Two new antibiotics, erav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deolankar, Manas S., Carr, Rachel A., Fliorent, Rebecca, Roh, Sean, Fraimow, Henry, Carabetta, Valerie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598263/ https://www.ncbi.nlm.nih.gov/pubmed/36289956 http://dx.doi.org/10.3390/antibiotics11101298

Ejemplares similares

Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant Acinetobacter baumannii: Understanding the Relationship between Microbicide and Antibiotic Resistance
por: Betchen, Melanie, et al.
Publicado: (2022)

In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study
por: Galani, Irene, et al.
Publicado: (2023)

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
por: Li, Anqi, et al.
Publicado: (2023)

Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
por: Alosaimy, Sara, et al.
Publicado: (2022)

In Vitro Activity of the Novel Tetracyclines, Tigecycline, Eravacycline, and Omadacycline, Against Moraxella catarrhalis
por: Sun, Xiang, et al.
Publicado: (2021)

253 Activity of Eravacycline Against Enterobacteriaceae and Acinetobacter baumannii from New York City
por: Abdallah, Marie, et al.
Publicado: (2014)

In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria
por: Zhang, Tingting, et al.
Publicado: (2022)

2137. Real World Experience with Eravacycline for the Treatment of Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
por: Lim, Andy, et al.
Publicado: (2023)

Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
por: Abbey, Taylor, et al.
Publicado: (2022)

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis
por: Lee, Yi-Tzu, et al.
Publicado: (2020)

Cryo-EM Determination of Eravacycline-Bound Structures of the Ribosome and the Multidrug Efflux Pump AdeJ of Acinetobacter baumannii
por: Zhang, Zhemin, et al.
Publicado: (2021)

In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates
por: Zeng, Weiliang, et al.
Publicado: (2022)

Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains
por: Kesavan, DineshKumar, et al.
Publicado: (2020)

1586. A Comparative Analysis of In Vitro Susceptibilities of Vancomycin-Resistant Enterococci Against Doxycycline, Minocycline, Tigecycline, Eravacycline and Omadacycline
por: Chua, Mary Francine P, et al.
Publicado: (2020)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates
por: Lee, Hyukmin, et al.
Publicado: (2016)

Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
por: Trebosc, Vincent, et al.
Publicado: (2019)

Complete Genome Sequences of Four Extensively Drug-Resistant Acinetobacter baumannii Isolates from Thailand
por: Chopjitt, Peechanika, et al.
Publicado: (2020)

Investigations on Acinetophage, QAB 3.4, Targeting Extensively Drug-Resistant Acinetobacter baumannii Isolates
por: Hussain, Aamir, et al.
Publicado: (2021)

Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
por: Komp Lindgren, Patricia, et al.
Publicado: (2016)

Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates
por: Aliakbarzade, Katayun, et al.
Publicado: (2014)

Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii
por: Ghajavand, Hasan, et al.
Publicado: (2017)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
por: Hong, Yoon-Kyoung, et al.
Publicado: (2020)

Characterization of Acinetobacter baumannii Isolated from Raw Milk
por: Mohamed, Hams M. A., et al.
Publicado: (2022)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Insights into Acinetobacter baumannii protective immunity
por: Jeffreys, Sean, et al.
Publicado: (2022)

Draft Genome Sequences of Two Extensively Drug-Resistant Acinetobacter baumannii Strains Isolated from Pus Samples
por: Mahalingam, Niranjana, et al.
Publicado: (2016)

Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-Resistant Acinetobacter baumannii Isolates
por: Marazzato, Massimiliano, et al.
Publicado: (2022)

Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
por: Dagher, Michael, et al.
Publicado: (2020)

Extensively drug-resistant Acinetobacter baumannii: role of conjugative plasmids in transferring resistance
por: Ababneh, Qutaiba, et al.
Publicado: (2023)

Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China
por: Wen, Zewen, et al.
Publicado: (2020)

Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants
por: Liu, Fei, et al.
Publicado: (2014)

Draft Genome Sequences of Two Extensively Drug-Resistant Strains of Acinetobacter baumannii Isolated from Clinical Samples in Pakistan
por: Lomonaco, Sara, et al.
Publicado: (2020)

Identification of an Outbreak Cluster of Extensively Antibiotic-Resistant GC1 Acinetobacter baumannii Isolates in U.S. Military Treatment Facilities
por: Luo, Ting L., et al.
Publicado: (2023)

Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
por: Vakili, Bahareh, et al.
Publicado: (2014)

Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes
por: Altun, Hatice Uludag, et al.
Publicado: (2014)

Draft Genome Sequences of 11 Clinical Isolates of Acinetobacter baumannii
por: Higgins, P. G., et al.
Publicado: (2016)

Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates
por: Shenkutie, Abebe Mekuria, et al.
Publicado: (2020)

Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
por: Jo, Jeongwoo, et al.
Publicado: (2021)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q2ncm0vd9uhsepcij8b9had9mb